Your Health, We Care
Another NameDostinex,LuciCaber,卡麦角林
IndicationsIt is indicated for the treatment of hyperprolactinemia in adults, including conditions caused by idiopathic factors or pituitary adenomas.
Reg No.03 L 1322/25
Inspection NO.568-25
Cabergoline produced by Lucius Pharmaceuticals offers patients a convenient and cost-effective treatment option due to its long-acting effect and lower dosing frequency.
Summary of Key Information for Cabergoline.
The main active ingredient is cabergoline, which belongs to the class of ergot derivative dopamine receptor agonists.
It is indicated for adult patients with hyperprolactinemia.
The recommended initial dose is 0.25 mg, taken orally twice a week. The dose can be gradually adjusted based on the patient’s response, with a maximum dose of 1 mg twice a week.Reference Article: Dosage and Administration of Cabergoline
Special populations such as pregnant women and patients with liver impairment need dose adjustments or should avoid use after evaluation by a physician.
In case of overdose, blood pressure support measures should be taken immediately, and professional medical assistance should be sought promptly.
The medication should be stored in its original packaging at room temperature (20°C–25°C).
After oral administration, the drug reaches peak concentration within 2–3 hours. It has a long half-life and is mainly excreted via feces and urine.
FDA，2025.04
